| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/03/2023 | BIODESIX INC | BDSX | Grant | Common Stock | 6.2k | $1.62 | $10k | By The Jon Faiz Kayyem Revocable Trust | 08/03/2023 |
| 05/23/2023 | BIODESIX INC | BDSX | Grant | Restricted Stock Units | 28.9k | $0.00 | $0 | | 05/23/2023 |
| 03/31/2023 | BIODESIX INC | BDSX | Exercise | Restricted Stock Units | 145.8k | $0.00 | $0 | | 03/31/2023 |
| 01/23/2023 | Inhibrx, Inc. | INBX | Sale | Common Stock | 9.5k | $25.26 | $240k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 01/23/2023 |
| 01/03/2023 | BIODESIX INC | BDSX | Grant | Restricted Stock Units | 4.9k | $0.00 | $0 | | 01/03/2023 |
| 01/01/2023 | BIODESIX INC | BDSX | Grant | Restricted Stock Units | 62.5k | $0.00 | $0 | | 01/01/2023 |
| 11/21/2022 | Inhibrx, Inc. | INBX | Sale | Common Stock | 6.8k | $30.12 | $203.8k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 11/21/2022 |
| 11/21/2022 | BIODESIX INC | BDSX | Purchase | Common Stock | 173.9k | $1.15 | $200k | By The Jon Faiz Kayyem Revocable Trust | 11/21/2022 |
| 11/21/2022 | Inhibrx, Inc. | INBX | Sale | Common Stock | 2.7k | $29.33 | $80.2k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 11/21/2022 |
| 08/24/2022 | Inhibrx, Inc. | INBX | Gift | Common Stock | 11.9k | $0.00 | $0 | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 08/24/2022 |
| 08/05/2022 | Inhibrx, Inc. | INBX | Gift | Common Stock | 3.4k | $0.00 | $0 | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 08/05/2022 |
| 08/02/2022 | Inhibrx, Inc. | INBX | Gift | Common Stock | 25k | $0.00 | $0 | By Child A | 08/02/2022 |
| 08/02/2022 | Inhibrx, Inc. | INBX | Gift | Common Stock | 118.5k | $0.00 | $0 | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 08/02/2022 |
| 05/25/2022 | Inhibrx, Inc. | INBX | Grant | Stock Option (right to buy) | 15k | $12.57 | $188.6k | | 05/25/2022 |
| 05/24/2022 | BIODESIX INC | BDSX | Grant | Restricted Stock Units | 83.3k | $0.00 | $0 | | 05/24/2022 |
| 06/07/2021 | Inhibrx, Inc. | INBX | Grant | Stock Option (right to buy) | 15k | $24.78 | $371.7k | | 06/07/2021 |
| 02/02/2018 | GenMark Diagnostics, Inc. | GNMK | Sale | Common Stock | 148 | $5.13 | $759.2 | | 02/02/2018 |
| 12/04/2017 | GenMark Diagnostics, Inc. | GNMK | Sale | Common Stock | 135 | $4.70 | $634.5 | | 12/04/2017 |
| 11/20/2017 | GenMark Diagnostics, Inc. | GNMK | Sale | Common Stock | 1.3k | $4.74 | $6k | | 11/20/2017 |
| 11/02/2017 | GenMark Diagnostics, Inc. | GNMK | Sale | Common Stock | 135 | $7.24 | $977.4 | | 11/02/2017 |
| 09/05/2017 | GenMark Diagnostics, Inc. | GNMK | Sale | Common Stock | 133 | $9.75 | $1.3k | | 09/05/2017 |
| 08/21/2017 | GenMark Diagnostics, Inc. | GNMK | Sale | Common Stock | 1.3k | $9.45 | $12.1k | | 08/21/2017 |
| 06/02/2017 | GenMark Diagnostics, Inc. | GNMK | Sale | Common Stock | 132 | $12.89 | $1.7k | | 06/02/2017 |